INTERNATIONAL PATENT: PERRON INSTITUTE FOR NEUROLOGICAL AND TRANSLATIONAL SCIENCE LIMITED FILES APPLICATION FOR "ANTISENSE TREATMENT FOR METABOLIC DISEASES"

GENEVA, Feb. 7 -- PERRON INSTITUTE FOR NEUROLOGICAL AND TRANSLATIONAL SCIENCE LIMITED (Ground Floor, RR Block, QEII Medical Centre8 Verdun StreetNedlands, Western Australia 6009) filed a patent application (PCT/AU2025/050790) for "ANTISENSE TREATMENT FOR METABOLIC DISEASES" on Jul 24, 2025. With publication no. WO/2026/025143, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOKS, Sulev (273 Churchill AvenueSubiaco, Western Australia 6008)

Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicin...